title: Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma.
authors: Eun Hye
authors: EH
authors: Kim
authors: Beom Kyung
authors: BK
authors: Kim
authors: Do Young
authors: DY
authors: Kim
authors: Seung Up
authors: SU
authors: Kim
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004334:Drug Administration Schedule; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000008:administration & dosage*; D018714:Radiotherapy, Adjuvant; D000077157:Sorafenib; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D015021:Yttrium Radioisotopes; D009536:Niacinamide; D000077157:Sorafenib